Rebound of relapses after discontinuation of rituximab in a patient with MOG-IgG1 positive highly relapsing optic neuritis: a case report

BACKGROUND: Myelin oligodendrocyte glycoprotein immunoglobulin G1 (MOG-IgG1)-associated disease is suggested as a separate disease entity distinct from multiple sclerosis and neuromyelitis optica spectrum disorder. Nonetheless, the optimal treatment regimen for preventing relapses in MOG-IgG1-associ...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Neurol
Asıl Yazarlar: Choi, Seok-Jin, Kim, Boram, Lee, Haeng-Jin, Kim, Seong-Joon, Kim, Sung-Min, Sung, Jung-Joon
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2018
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6302456/
https://ncbi.nlm.nih.gov/pubmed/30577778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-018-1222-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller